Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrifazimine Phase II EBA Study in Drug-Susceptible Pulmonary Tuberculosis
CTR20202345Phase 2Completed
- Sponsor
- Beijing Xiehe Pharmaceutical
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfazimine in Tuberculosis (TB), sponsored by Beijing Xiehe Pharmaceutical. Started Nov 2020; status: completed.
02
Drugs
pirfazimine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20202345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202345.